Results from the RAPID-MIRACLE trial have found, for the first time, that the widely used MIRACLE2 risk score can be applied outside a hospital setting to accurately predict brain injury following a ...
Complete financial results are included in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2026, which has been filed with the U.S. Securities and Exchange ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing ...
An artificial intelligence (AI)-based method for interpreting ECGs performed better than standard approaches in detecting occlusive myocardial infarction (MI), according to a study presented at ESC ...
Romano-Ward syndrome, the most common congenital long QT disorder, often causes exertion- or stimulus-triggered syncope and ...
Researchers developed a multiview AI model that analyzes multiple echocardiogram images simultaneously, improving detection ...
New solution brings advanced vascular analysis into the cvi42 cardiovascular imaging ecosystemHighlights Circle ...
The field of cardiovascular diagnostics is undergoing a transformative shift with the advent of artificial intelligence (AI)-enhanced electrocardiography ...
The rapid digitization of healthcare is transforming patient care, but it is also creating new vulnerabilities as cyber threats grow more sophisticated and widespread. From ransomware attacks to data ...
New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep tracking — while cautioning that many of them are insufficiently validated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results